Changgeng Fu

654 total citations
55 papers, 348 citations indexed

About

Changgeng Fu is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Molecular Biology. According to data from OpenAlex, Changgeng Fu has authored 55 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 17 papers in Complementary and alternative medicine and 15 papers in Molecular Biology. Recurrent topics in Changgeng Fu's work include Traditional Chinese Medicine Analysis (9 papers), Traditional Chinese Medicine Studies (9 papers) and Blood Pressure and Hypertension Studies (6 papers). Changgeng Fu is often cited by papers focused on Traditional Chinese Medicine Analysis (9 papers), Traditional Chinese Medicine Studies (9 papers) and Blood Pressure and Hypertension Studies (6 papers). Changgeng Fu collaborates with scholars based in China and United States. Changgeng Fu's co-authors include Keji Chen, Peili Wang, Zhu-ye Gao, Hua Qu, Dazhuo Shi, Jiarui Wu, Qiaoning Yang, Jiawei Zhang, Dazhuo Shi and Zhen Yang and has published in prestigious journals such as Journal of Ethnopharmacology, Medicine and Theranostics.

In The Last Decade

Changgeng Fu

49 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Changgeng Fu China	12	143	85	74	47	40	55	348
Aijun Liu China	11	128 0.9×	97 1.1×	109 1.5×	39 0.8×	29 0.7×	23	379
Xianliang Wang China	12	169 1.2×	130 1.5×	121 1.6×	71 1.5×	39 1.0×	57	417
Zhong-Qi Yang China	9	149 1.0×	73 0.9×	82 1.1×	47 1.0×	41 1.0×	43	360
Jinqiang Zhu China	11	106 0.7×	65 0.8×	32 0.4×	41 0.9×	34 0.8×	22	333
Yuxue Yang China	12	133 0.9×	50 0.6×	65 0.9×	75 1.6×	26 0.7×	23	341
Qiaoning Yang China	10	115 0.8×	59 0.7×	50 0.7×	31 0.7×	17 0.4×	24	277
Hanlai Zhang China	8	183 1.3×	35 0.4×	68 0.9×	26 0.6×	30 0.8×	10	398
Qianqian Dong China	10	226 1.6×	52 0.6×	74 1.0×	27 0.6×	28 0.7×	23	464
Shi-Hao Ni China	9	206 1.4×	29 0.3×	73 1.0×	36 0.8×	45 1.1×	40	449
Yuanyuan Tie China	7	230 1.6×	37 0.4×	88 1.2×	36 0.8×	34 0.8×	7	415

Countries citing papers authored by Changgeng Fu

Since Specialization

Citations

This map shows the geographic impact of Changgeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changgeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changgeng Fu more than expected).

Fields of papers citing papers by Changgeng Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changgeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changgeng Fu. The network helps show where Changgeng Fu may publish in the future.

Co-authorship network of co-authors of Changgeng Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Changgeng Fu. A scholar is included among the top collaborators of Changgeng Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changgeng Fu. Changgeng Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Yingdong, Aling Shen, Daxin Chen, et al.. (2024). Dehydrocorydaline attenuates myocardial ischemia-reperfusion injury via the FoXO signalling pathway: A multimodal study based on network pharmacology, molecular docking, and experimental study. Journal of Ethnopharmacology. 337(Pt 1). 118738–118738. 5 indexed citations

Liao, Feifei, et al.. (2024). Elucidating Iron Metabolism through Molecular Imaging. Current Issues in Molecular Biology. 46(4). 2798–2818.

Wang, Yueqi, et al.. (2024). Enhanced TfR1 Recognition of Myocardial Injury after Acute Myocardial Infarction with Cardiac Fibrosis via Pre-Degrading Excess Fibrotic Collagen. Biology. 13(4). 213–213. 1 indexed citations

Qu, Hua, Kuo Yang, Wanqing Li, et al.. (2024). Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial. Pharmacological Research. 200. 107052–107052. 1 indexed citations

Gao, Jie, Xiaojuan Ma, Fang Lü, et al.. (2024). Effects of ginseng berry saponins from panax ginseng on glucose metabolism of patients with prediabetes: A randomized, double-blinded, placebo-controlled, crossover trial. Phytomedicine. 132. 155842–155842. 3 indexed citations

Fan, Linlin, Wanqing Li, Wenwen Yang, et al.. (2024). Delivery of liquid metal particles and tanshinone IIA into the pericardial cavity for myocardial infarction treatment. Journal of Materials Chemistry B. 12(46). 11916–11925. 4 indexed citations

Yang, Wenwen, et al.. (2023). Association of body mass index trajectory and hypertension risk: A systematic review of cohort studies and network meta-analysis of 89,094 participants. Frontiers in Cardiovascular Medicine. 9. 941341–941341. 7 indexed citations

Peng, Yuxuan, et al.. (2023). Association between weight change and the predicted 10-year risk for atherosclerosis cardiovascular disease among U.S. older adults: data from National Health and Nutrition Examination Survey 1999–2018. Frontiers in Public Health. 11. 1183200–1183200. 6 indexed citations

Zhang, Guoyuan, et al.. (2023). Effects and mechanism of Kedaling tablets for atherosclerosis treatment based on network pharmacology, molecular docking and experimental study. Journal of Ethnopharmacology. 319(Pt 1). 117108–117108. 7 indexed citations

10.

Wen, Ying, Xiuli Zhang, Lihui Wei, et al.. (2023). Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology analysis. Frontiers in Pharmacology. 14. 1082281–1082281. 12 indexed citations

11.

Chen, Li, et al.. (2023). Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event. Frontiers in Cardiovascular Medicine. 9. 994329–994329. 6 indexed citations

12.

Yang, Qiaoning, Ming Guo, Z Gao, et al.. (2022). The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort Study. Phytomedicine. 109. 154554–154554. 11 indexed citations

13.

Fu, Changgeng, et al.. (2022). Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm. Annals of Translational Medicine. 10(10). 547–547. 16 indexed citations

14.

Lu, Shan, Ziqi Meng, Yingying Tan, et al.. (2022). An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification. BMC Complementary Medicine and Therapies. 22(1). 54–54. 6 indexed citations

15.

Ni, Mengwei, Haojia Wang, Wei Zhou, et al.. (2021). A Multidimensional Bayesian Network Meta-Analysis of Chinese Herbal Injections for Treating Non-small Cell Lung Cancer With Gemcitabine and Cisplatin. Frontiers in Pharmacology. 12. 739673–739673. 5 indexed citations

16.

Qu, Hua, Ning Wang, Ming Guo, et al.. (2020). Prediction of the Network Pharmacology‐Based Mechanism for Attenuation of Atherosclerosis in Apolipoprotein E Knockout Mice by Panax notoginseng Saponins. Evidence-based Complementary and Alternative Medicine. 2020(1). 8574702–8574702. 6 indexed citations

17.

Meng, Ziqi, Jiarui Wu, Yingli Zhu, et al.. (2020). Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach. Chinese Journal of Integrative Medicine. 27(1). 62–69. 15 indexed citations

18.

Chen, Keji, et al.. (2016). Diagnostic criterion of blood stasis syndrome for coronary heart disease. Chinese Journal of Integrative Medicine. 22(11). 803–804. 8 indexed citations

19.

Zhang, Lei, Qiaoning Yang, Zhu-ye Gao, et al.. (2016). Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial. Chinese Journal of Integrative Medicine. 23(10). 740–746. 3 indexed citations

20.

Liu, Longtao, Songzi Wang, Changgeng Fu, et al.. (2016). Comparison of Beneficial Effects of Acupuncture at PC6, LU7 & Non-acupuncture Points on Cardiac Cell Function in Myocardial Ischemia (MI) Rats by Testing Protein Expression of L-type Calcium Channel Protein and its Related Protein. Acupuncture & Electro-Therapeutics Research. 41(2). 107–125. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact